Skip to main content

VITAMIN D AND HYPERTENSION

E-mail
marijanajandrickocic@gmail.com
Ustanova
Primary Health care Center Krupa na Uni, Republic of Srpska, BiH
Reference
Kalil G, Haynes W. Sympathetic nervous system in obesity­related hypertension: mec- hanisms and clinical implications. Hypertens Res. 2012;35:4–16. Available from: https:// doi.org/10.1038/hr.2011.173
Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment. Metabolites. 2021;11(4):255. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074587/
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, DelValleet HB, Breiner H, Bandyal A et al editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): Na
Sažetak

VITAMIN D AND HYPERTENSION

Medicinski glasnik

The impact of co/polymorbidity on the therapeutic response to vitamin D in patients with osteoporosis and vitamin D hypovitaminosis in primary health care

E-mail
f.mihajlovic@yahoo.com
Ustanova
University of Kragujevac, Faculty of Medical Sciences
University of Kragujevac, Faculty of Science Kragujevac
Clinical Center Kragujevac
Novi Pazar General Hospital
Clinical Center of Serbia
Reference
Holick MF. Sunlightand vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. 2004; 80(6 Suppl): 1678S-88S.
Holick M. Vitamin D: a D-light full health perspective. 2008; 66(Suppl2): 182–94.
Płudowski P, Karczmarewicz E, Bayer M, et all. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groupsat risk of vitamin D deficiency. 2
Sažetak

The impact of co/polymorbidity on the therapeutic response to vitamin D in patients with osteoporosis and vitamin D hypovitaminosis in primary health care

Medicinski glasnik